Ortho Retin-A approval
Executive Summary
Lower dose (.025%) cream formulation approved by FDA on Sept. 23. The new product joins .1% crea, .025% gel and .05% liquid formulations. No new indications were approved. New "milder" cream will be introduced by the end of the year, Ortho said. The company has scheduled a press conference for Oct. 18 to announce the approval and to report on new Retin-A studies.